-
Tytuł:
-
[Epidemiology of stroke and cerebral protection in patients undergoing transcatheter aortic valve replacement].
-
Autorzy:
-
Testa L; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
Pero G; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
Bollati M; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
Casenghi M; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
Popolo Rubbio A; Dipartimento di Cardiologia, Policlinico Vittorio Emanuele, Università degli Studi, Catania.
Cuman M; Dipartimento di Medicina, Università degli Studi, Verona.
Agnifili M; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
Pizzocri S; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
Bedogni F; Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).
-
Transliterated Title:
-
Epidemiologia e prevenzione dell’ictus in pazienti sottoposti ad impianto transcatetere di valvola aortica.
-
Źródło:
-
Giornale italiano di cardiologia (2006) [G Ital Cardiol (Rome)] 2019 Mar; Vol. 20 (3 Suppl 1), pp. 17S-22S.
-
Typ publikacji:
-
Journal Article; Review
-
Język:
-
Italian
-
Imprint Name(s):
-
Publication: Roma : Il Pensiero Scientifico Editore
Original Publication: Roma : CEPI-AIM Group, [2006]-
-
MeSH Terms:
-
Aortic Valve Stenosis/*surgery
Stroke/*prevention & control
Transcatheter Aortic Valve Replacement/*methods
Humans ; Incidence ; Quality of Life ; Risk Factors ; Stroke/epidemiology ; Stroke/etiology ; Transcatheter Aortic Valve Replacement/adverse effects
-
Entry Date(s):
-
Date Created: 20190312 Date Completed: 20191206 Latest Revision: 20191217
-
Update Code:
-
20240105
-
DOI:
-
10.1714/3121.31037
-
PMID:
-
30855028
-
The introduction into clinical practice of transcatheter aortic valve implantation (TAVI) has led to a significant change in the therapeutic paradigm for patients with valvular aortic stenosis. However, in parallel with the benefits obtained in prognosis and quality of life, an inherent risk of major cerebral thromboembolic events has been observed. In different studies this risk has been estimated between 2% and 6%. In order to reduce the incidence of cerebrovascular accidents during TAVI, several brain protection systems have been developed but, to date, none has obtained sufficient clinical evidence to be implemented on a large scale, and they are therefore used only in selected cases. Furthermore, periprocedural drug therapy and follow-up are still the subject of extensive discussion in the scientific community. This paper reviews the topic of stroke prevention in patients undergoing TAVI for both the periprocedural and postprocedural aspects.